Suppr超能文献

miR-210 靶向 BCL11A mRNA:调节 γ-珠蛋白基因表达的可能网络。

BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression.

机构信息

Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy.

Laboratory for the Development of Pharmacological and Pharmacogenomic Therapy of Thalassaemia, Biotechnology Center, Ferrara University, 44121 Ferrara, Italy.

出版信息

Int J Mol Sci. 2017 Nov 26;18(12):2530. doi: 10.3390/ijms18122530.

Abstract

The involvement of microRNAs in the control of repressors of human gene transcription has been firmly demonstrated, as described for the miR-486-3p mediated down-regulation of BCL11A. On the other hand, we have reported that miR-210 is involved in erythroid differentiation and, possibly, in gene up-regulation. In the present study, we have identified the coding sequence of BCL11A as a possible target of miR-210. The following results sustain this hypothesis: (a) interactions between miR-210 and the miR-210 BCL11A site were demonstrated by SPR-based biomolecular interaction analysis (BIA); (b) the miR-210 site of BCL11A is conserved through molecular evolution; (c) forced expression of miR-210 leads to decrease of BCL11A-XL and increase of γ-globin mRNA content in erythroid cells, including erythroid precursors isolated from β-thalassemia patients. Our study suggests that the coding mRNA sequence of BCL11A can be targeted by miR-210. In addition to the theoretical point of view, these data are of interest from the applied point of view, supporting a novel strategy to inhibit BCL11A by mimicking miR-210 functions, accordingly with the concept supported by several papers and patent applications that inhibition of BCL11A is an efficient strategy for fetal hemoglobin induction in the treatment of β-thalassemia.

摘要

miRNAs 参与人类基因转录抑制因子的调控已得到充分证实,例如 miR-486-3p 介导的 BCL11A 下调。另一方面,我们已经报道 miR-210 参与红细胞分化,并可能参与基因上调。在本研究中,我们鉴定了 BCL11A 的编码序列作为 miR-210 的可能靶标。以下结果支持这一假设:(a)通过基于 SPR 的生物分子相互作用分析(BIA)证明了 miR-210 与 miR-210 BCL11A 结合位点之间的相互作用;(b)BCL11A 的 miR-210 结合位点在分子进化过程中是保守的;(c)在红细胞系中,包括从β地中海贫血患者中分离出的红细胞前体中,强制表达 miR-210 导致 BCL11A-XL 减少和 γ-珠蛋白 mRNA 含量增加。我们的研究表明,BCL11A 的编码 mRNA 序列可被 miR-210 靶向。除了理论观点外,这些数据从应用角度来看也很有意义,支持通过模拟 miR-210 功能来抑制 BCL11A 的新策略,这与几篇论文和专利申请的观点一致,即抑制 BCL11A 是治疗β地中海贫血症中诱导胎儿血红蛋白的有效策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65f1/5751133/fb75e4757468/ijms-18-02530-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验